Research
RGC thickness may be early retinal indicator with oral HCQ
Screening with SD-OCT may aid in identifying patients with retinal toxicity before visual field loss.
Business
AOAExcel endorses VisionHQ's in-office patient membership plans
Platform offers optometric practices in-house, customizable membership and subscription plans in lieu of traditional vision insurance for patients.
Products
myze launches daily lid-and-lash anti-microbial cleanser
The Foam is preservative-free and formulated with manuka honey, offering antimicrobial and anti-inflammatory effects for long-term ocular health.
Events
National Keratoconus Foundation raises awareness ahead of World KC Day
Recognized annually on Nov. 10, this year’s event features the Cones for a Cause campaign to spread the word and support patients across the country.
Pipeline
Outlook Therapeutics resubmits wet AMD BLA for bevacizumab
Company’s third submission of ONS-5010 (bevacizumab-vikg) reportedly addresses prior issues raised in the FDA’s company response letter.
Research
Advanced AMD linked to imbalanced gut microbiome
Though seemingly unrelated, gut flora may play a surprising role in the pathogenesis of age-related macular degeneration (AMD).
Pipeline
Sydnexis reports phase 3 topline data on SYD-101 eye drop for pediatric myopia
The STAR study met both primary and secondary endpoints for low-dose atropine formulation—just days after the FDA’s NDA rejection.
Research
Viatris and Locus Biosciences to develop antibacterial therapies for ophthalmic infections
Collaboration will utilize Locus’ advanced precision drug development platform to address increasing burden of antimicrobial resistance in eye infections.
Pipeline
Viridian submits BLA for veligrotug to treat TED
Company is requesting Priority Review of veli, an IGF-1R monoclonal antibody intravenously-administered to treat chronic TED.
Research
Myopia may delay DR development and progression
Study used Mendelian randomization to identify a causal relationship between myopia and diabetic retinopathy.Business
DefEYE and Celularity partner to advance ophthalmic biologics portfolios
Collaboration features a multi-million dollar investment in DefEYE as well as an exclusive sublicense of Celularity’s BIOVANCE amnion-derived ocular allografts.
Research
Women with osteoporosis more prone to AMD development
Study highlights the key role of declining estrogen levels in the risk of developing AMD and osteoporosis.
Products
Barti launches new AI guidelines for EHR
Practice management platform now offers a built-in tool that instantly references and applies evidence-based recommendations directly within patient charts.
Legal
The Vision Council calls for optical product exemption from new tariffs
Nonprofit responds to two ongoing national security investigations that have potential to lead to expanded tariffs on key optical medical devices and related products.
Products
Regeneron receives FDA CRL, delaying Eylea HD sBLA approval
Company plans to resubmit app for pre-filled syringe version in early 2026, noting two 2025 dates to watch for.
Pipeline
Nanoscope reports 3-year vision improvements for RP optogenetic therapy
Long-term extension from phase 2b/3 RESTORE trial notes potential of MCO-010 as a one-time, gene-agnostic optogenetic therapy.
Business
Smartlens raises $5.2 million to advance miLens FDA clearance and launch
Financing to support the ongoing advancement and FDA clearance process of the miLens, an electronics-free contact lens technology.
Business
Lilly to purchase Adverum Biotechnologies
With a Q4 closing date in mind, acquisition supports ongoing clinical trials and development activities for Ixo-vec, a one-time IVT gene therapy injection to treat wet AMD.
Business
Ciliatech to open US subsidiary supporting clinical advancement of novel glaucoma device
Upcoming clinical trials to study the Intercil Uveal Spacer, a cilioscleral interpositioning device that reestablishes the natural uveoscleral outflow.
Products